Isolation and Characterization of an Unknown Process-Related Impurity in Furosemide and Validation of a New HPLC Method
Molecules · 2023
DOI: 10.3390/molecules28052415 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Ao Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Marine Biological Resources and Environment, Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, School of …. Hauptthemen laut MEDLINE: Furosemide, Drug Contamination. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, Open-end Funds of Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, Scientific Research Foundation of Jiangsu Ocean University.
Abstract (Originalsprache)
Furosemide is a widely used loop diuretic in the treatment of congestive heart failure and edema. During the preparation of furosemide, a new process-related impurity G in the levels ranging from 0.08% to 0.13% was detected in pilot batches by a new high performance liquid chromatography (HPLC) method. The new impurity was isolated and characterized by comprehensive analysis of FT-IR, Q-TOF/LC-MS, 1D-NMR (1H, 13C, and DEPT), and 2D-NMR (1H-1H-COSY, HSQC, and HMBC) spectroscopy data. The possible formation pathway of impurity G was also discussed in detail. Moreover, a novel HPLC method was developed and validated for the determination of impurity G and the other six known impurities registered in the European Pharmacopoeia as per ICH guidelines. The HPLC method was validated with respect to system suitability, linearity, the limit of quantitation, the limit of detection, precision, accuracy, and robustness. The characterization of impurity G and the validation of its quantitative HPLC method were reported for the first time in this paper. Finally, the toxicological properties of impurity G were predicted by the in silico webserver ProTox-II.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of Marine Biological Resources and Environment, Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, School of Pharmacy, Jiangsu Ocean University, Lianyungang 222005, China.
- Co-Innovation Center of Jiangsu Marine Bio-Industry Technology, Jiangsu Ocean University, Lianyungang 222005, China.
- Xuzhou Institute for Food and Drug Control, Xuzhou 221000, China.
- Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China.
ORCID-Profile: Yin Chen, Tao Zhuang
Förderung
- Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions
- Open-end Funds of Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening
- Scientific Research Foundation of Jiangsu Ocean University
Zitieren
APA
Xu, A., Xue, Y., Zeng, Y., Li, J., Zhou, H., Wang, Z., Chen, Y., Chen, H., Jin, J., & Zhuang, T. (2023). Isolation and Characterization of an Unknown Process-Related Impurity in Furosemide and Validation of a New HPLC Method. Molecules. https://doi.org/10.3390/molecules28052415
Vancouver
Xu A, Xue Y, Zeng Y, Li J, Zhou H, Wang Z, et al. Isolation and Characterization of an Unknown Process-Related Impurity in Furosemide and Validation of a New HPLC Method. Molecules. 2023. doi:10.3390/molecules28052415
BibTeX
@article{Xu2023,
author = {Xu, Ao and Xue, Yunlin and Zeng, Yuyu and Li, Jing and Zhou, Huiling and Wang, Zhen and Chen, Yin and Chen, Hui and Jin, Jian and Zhuang, Tao},
title = {Isolation and Characterization of an Unknown Process-Related Impurity in Furosemide and Validation of a New HPLC Method},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28052415}
}
EUVIMED